Radiation Therapy

lung cancer, radiation therapy, immune checkpoint inhibitors, 2017 Multidisciplinary Thoracic Cancers Symposium, clinical study
News | Lung Cancer | March 22, 2017

March 22, 2017 — An emerging approach for cancer treatment seeks to combine...

SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017

March 20, 2017 — Patients in their 80s and 90s who have early-stage...

iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017

March 15, 2017 — iCAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with...

reducing radiation therapy, breast cancer, cut treatment costs, Duke Cancer Institute study
News | Radiation Therapy | March 14, 2017

March 14, 2017 — Over half of older women with early stage breast cancer received more...

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017

March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...

brain metastases, cancer, survey, UCLA, Dr. Percy Lee, whole brain radiotherapy, stereotactic radiosurgery

Image of a human brain with seven metastases, depicted here as the small colored spheres inside rectangles. Image courtesy of UCLA Jonsson Comprehensive Cancer Center.

News | Radiation Therapy | March 03, 2017

March 3, 2017 — An extensive study by University of California Los Angeles (UCLA) researchers found significant...

brain FUS

Brain FUS uses an array of about 1,000 elements designed to overcome attenuation issues presented by the skull and to diffuse the heating over a large area of the brain to prevent damaging healthly tissue. 

Feature | Radiation Oncology | March 02, 2017 | By Dave Fornell

Focused ultrasound (FUS), also called high-...

Accuray, cancer patient websites, CyberKnife, TomoTherapy, radiation therapy, radiotherapy, RT
News | Radiation Therapy | March 02, 2017

March 2, 2017 — The Internet is one of the first places patients turn to for healthcare information after receiving...

ViewRay, MRIdian Linac system, FDA 510k approval, MRI-guided radiation therapy
Technology | Image Guided Radiation Therapy (IGRT) | February 27, 2017

February 27, 2017 — ViewRay Inc. announced that the company received 510(k) clearance from the U.S. Food and Drug...

Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017

February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...

targeted radiosurgery, stereotactic radiosurgery, whole-brain radiation, brain tumor metastases, Cureus, University of Missouri School of Medicine study
News | Radiation Therapy | February 16, 2017

February 16, 2017 — University of Missouri (MU) School of Medicine researchers compared two common postsurgical...

ASTRO guideline, bone metastases, pallliative radiation therapy, gold standard
News | Radiation Therapy | February 14, 2017

February 14, 2017 — The American Society for Radiation Oncology (ASTRO) recently published an updated clinical...

Accuray, Radixact treatment delivery system, TomoTherapy, Shonin approval, Japan
News | Radiation Therapy | February 13, 2017

February 13, 2017 — Accuray Inc. announced that it has received Shonin approval from the Japanese Ministry of Health...

state of the proton therapy market entering 2017, proton therapy, radiation therapy, Robust Insight survey
News | Proton Therapy | February 10, 2017

February 10, 2017 — Independent market research consultancy Robust Insight recently conveyed a survey commissioned...

EGFR mutant lung cancer, brain metastases, order of treatment, radiation therapy, EGFR-directed drugs, Journal of Clinical Oncology study
News | Lung Cancer | February 09, 2017

February 9, 2017 — A study published in the...

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.
News | Radiation Therapy | February 07, 2017

February 7, 2017 — IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its...

Institut Curie, Onxeo, radiotherapy, immunotherapy, DNA repair inhibitors, AsiDNA, DBait
News | Radiation Therapy | February 06, 2017

February 6, 2017 — Onxeo S.A. and the Institut Curie launched a series of studies on World Cancer Day (Feb. 4) aimed...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

February 6, 2017 — A study published in the February issue of...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...

Overlay Init